The Federal Bureau of Investigation has issued an alert to inform organizations in the United States of the risk associated with the use of Chinese tax software.
The alert aims at informing US companies in the healthcare, chemical, and
finance sectors of cyber espionage activity by the Chinese government against their business and branches operating in China.
“Compromise of the pharmaceutical supply chain provides malicious actors opportunities for theft of US intellectual property, while public disclosure can cause cascading effects including loss of public trust in both chemical and healthcare institutions.” reads the alert. “As previously highlighted in FBI PIN 20200521-001 released on 21 May 2020 and the US Department of Homeland Security’s joint advisory with Britain’s National Cyber Security Centre, hackers continue to “actively target organizations that include healthcare bodies, pharmaceutical companies, academia, medical research organizations, and local governments.”